Cynics will scoff at Donald Trump’s latest initiative: issuing an executive order forcing pharmaceutical companies to lower the prices of medical drugs used by US patients by between 30 and 80 percent.
The President wants to impose what he calls a “most favored nation” rule, under which drugs companies would be allowed to charge US consumers no more than they charge in the lowest-priced country where they sell their product.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in